The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final results of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomized study by the European Lung Cancer Working Party.
T. Berghmans
No relevant relationships to disclose
J. Lafitte
No relevant relationships to disclose
V. Giner
No relevant relationships to disclose
M. Berchier
No relevant relationships to disclose
A. Scherpereel
No relevant relationships to disclose
M. Paesmans
No relevant relationships to disclose
A. Meert
No relevant relationships to disclose
T. Bosschaerts
No relevant relationships to disclose
N. Leclercq
No relevant relationships to disclose
J. P. Sculier
No relevant relationships to disclose